Catalyst event

Alnylam Pharmaceuticals Inc (ALNY)

From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)

JPMorgan lowered its Alnylam price target to $400 from $420 while maintaining an Overweight rating.

Korean translation

JP모건이 알나일람의 목표주가를 420달러에서 400달러로 낮추고 비중확대 의견을 유지함.